OUTSOURCE
LUNG CANCER 12 GENE PANEL WITH PDL1 - VENTANA SP263 (Z1049)
Also Known As:
LUNG CANCER 12 GENE PANEL WITH PDL1 - VENTANA SP263
About This Test
This panel aids in prognostication and therapeutic decisions for Lung carcinoma where mutation has been demonstrated in ALK, BRAF, EGFR, ERBB2, KRAS, MAP2K1, MET, NRAS, PIK3CA, ROS1, TP53 and Fusion in ALK, RET, ROS1, NTRK; MET exon 14 skipping. It also enables the screening of clinically actionable targets for personalized targeted medicine in Lung adenocarcinoma. PD-L1 (SP263) expression by IHC is used to guide immunotherapy decisions.
Home Collection
✗ Not Available
Reports Available In
1 Day
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
Block must contain at least 10% tumor tissue. Physician prescription is mandatory.
The Lung Cancer 12 Gene Panel with PD-L1 (VENTANA SP263) is important because it helps personalize lung cancer treatment by identifying genetic mutations and PD-L1 expression.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
